Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Deng

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 3, 2020
Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancerRajan Sharma Bhattarai, Virender Kumar, Svetlana Romanova, et al.
British Journal of Pharmacology|December 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancerRui Wang, Chun Cai, Shanshan Deng, et al.
Bioorganic Chemistry|September 5, 2020
Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitorsSouvik Banerjee, Derek D Norman, Shanshan Deng, et al.
Molecular Cancer Therapeutics|October 25, 2019
An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane ResistanceShanshan Deng, Raisa I Krutilina, Qinghui Wang, et al.
Biochemical and Biophysical Research Communications|November 13, 2010
A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasisRui Liu, Yiming Li, Renmin Hu, et al.
Fitoterapia|December 3, 2014
Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivoDongliang Cao, Yun Sun, Ling Wang, et al.
Journal of Medicinal Chemistry|February 7, 2018
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor EfficacySouvik Banerjee, Kinsie E Arnst, Yuxi Wang, et al.
Frontiers in Pharmacology|September 24, 2021
MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting eEF1A1Yulan Liu, Shanshan Deng, Zhibing Song, et al.
Cancer Letters|January 3, 2023
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasisShanshan Deng, Souvik Banerjee, Hao Chen, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low ToxicitySicheng Zhang, Luis O Romero, Shanshan Deng, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 3, 2020
Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancerRajan Sharma Bhattarai, Virender Kumar, Svetlana Romanova, et al.
British Journal of Pharmacology|December 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancerRui Wang, Chun Cai, Shanshan Deng, et al.
Bioorganic Chemistry|September 5, 2020
Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitorsSouvik Banerjee, Derek D Norman, Shanshan Deng, et al.
Molecular Cancer Therapeutics|October 25, 2019
An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane ResistanceShanshan Deng, Raisa I Krutilina, Qinghui Wang, et al.
Biochemical and Biophysical Research Communications|November 13, 2010
A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasisRui Liu, Yiming Li, Renmin Hu, et al.
Fitoterapia|December 3, 2014
Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivoDongliang Cao, Yun Sun, Ling Wang, et al.
Journal of Medicinal Chemistry|February 7, 2018
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor EfficacySouvik Banerjee, Kinsie E Arnst, Yuxi Wang, et al.
Frontiers in Pharmacology|September 24, 2021
MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting eEF1A1Yulan Liu, Shanshan Deng, Zhibing Song, et al.
Cancer Letters|January 3, 2023
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasisShanshan Deng, Souvik Banerjee, Hao Chen, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low ToxicitySicheng Zhang, Luis O Romero, Shanshan Deng, et al.
Pageof 12